Camtek LTD is a US-listed company in the semiconductor materials & equipment industry. Its financial year ends in December.
Loading chart…
Third-party market data · may be delayed
~$77
Cash-flow model
Base case. Range ~$57–$100 across our lower- and higher-growth cases (10.6%–20.6% a year).
Overvalued
The price is above our entire value range; our base value is 29% below it.
Price used: $108.25, November 2, 2026
Camtek LTD valuation: adjust assumptions and compare models →
What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.
Revenue for the twelve months was $496m, up 15.6% on a year earlier, slower than the 36.1% growth a quarter earlier. Free-cash-flow margin rose to 25.6% from 21.1% a year earlier. It passes 2 of our 2 financial-health checks. Our cash-flow model value is $70.71 a share, against a share price of $117.
Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.
Camtek LTD's trailing-twelve-month revenue grew 15.6% year on year, with a free-cash-flow margin of 25.6%. Where it stands out: free-cash-flow margin of 25.6% ranks 4 of 20 semiconductor materials & equipment companies we cover. Where it lags: change in growth rate of -20.5pp ranks 20 of 20 semiconductor materials & equipment companies we cover.
Our discounted-cash-flow model values the business at ~$77 per share in the base case (~$57–$100 across growth scenarios) — model values under stated assumptions, not a price target.
Current signal Free cash flow diverging from earnings: TTM free cash flow grew 13.6% while net income fell 57.2%: a 71pp divergence.
Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.
Loading chart…
Third-party market data · may be delayed
Company announcements, filed results and changes that matter to shareholders.
The share price implies about 22.3% a year of cash-flow growth for five years.That is close to the 26.1% a year revenue growth Camtek has delivered.
Our cash-flow model with every input fixed except growth over the next five years, solved for the growth at which the model value equals the share price ($113.48, Nov 3, 2026). Cash-flow growth then fades to 2.5% a year; discount rate 8.5%. Delivered figures are revenue growth from SEC filings. This is a model exercise, not investment advice or a forecast of the share price. All companies
Our value per share comes from a discounted-cash-flow model of Camtek LTD's free cash flow after stock-based pay ( $106M, FY2025 Q4 TTM, with after-tax interest added back): growth for five years as below (the first two years from forecasts, guidance and the company's record), fading to 2.5%, discounted at 8.5%, then cash added and debt and other claims subtracted. These are model values under stated assumptions, not price targets or recommendations.
We value Camtek LTD as an operating company, with every model that fits that kind of business. Cost of equity 12.3%: the 10-year Treasury yield (4.9%) plus a beta of 1.64 times a 4.5% equity risk premium.
| Model | Value per share | In the combined value? |
|---|---|---|
| Cash-flow model (DCF) Free cash flow to the firm (after stock pay, with after-tax interest added back), grown then faded to 2.5%, discounted at 8.5% as the firm rate, less debt and other claims. | ~$77 ~$57–$100 | Primary model, counts double |
| Growth cash-flow model Revenue for this year and next from analysts' consensus, then growth fading to 2.5%; the operating margin moving to profitable peers'; investment needed per dollar of growth from peers; reduced by a failure probability. For young or fast-growing companies. The starting margin is normalized to between -100% and 60%; net margin is a proxy when operating income is not tagged. Uses analysts' consensus estimates (third-party data), not our forecasts. | ~$51 ~$30–$69 | Included |
| Forward price-to-earnings vs peers Next year's consensus earnings per share times peers' typical (harmonic-mean) forward price-to-earnings. Uses analysts' consensus estimates (third-party data), not our forecasts. | ~$81 ~$71–$110 | Included |
| Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. | ~$26 ~$20–$35 | Included |
| Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. | ~$24 ~$21–$26 | Included |
| Combined value Weighted average of the models that apply: the primary model (cash-flow model (dcf)) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. | ~$56 ~$24–$81 | 5 models |
Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Camtek LTD with Semiconductor Materials & Equipment in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.
| Discount rate ↓ / growth → | −5% growth | 0% growth | 5% growth | 10% growth | 15% growth | 20% growth |
|---|---|---|---|---|---|---|
| 7% | $28 | $40 | $56 | $77 | $104 | $139 |
| 8.5% | $20 | $29 | $40 | $55 | $74 | $99 |
| 10% | $15 | $22 | $31 | $42 | $57 | $76 |
| At fiscal year end | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share price | $2.01 | $3.05 | $5.42 | $6.53 | $10.65 | $21.56 | $45.30 | $21.60 | $68.26 | $80.77 | $106.35 |
| Market value | $67m | $108m | $195m | $240m | $409m | $870m | $2.0bn | $1.0bn | $3.3bn | $4.0bn | $5.3bn |
| + Net debt (− = net cash) | −$31m | −$20m | −$44m | −$55m | −$38m | −$106m | −$47m | $48m | $77m | $72m | $342m |
| Enterprise value | $36m | $88m | $151m | $185m | $371m | $764m | $2.0bn | $1.1bn | $3.4bn | $4.1bn | $5.7bn |
| Multiples | |||||||||||
| Price / sales | 1.0x | 1.4x | 2.1x | 1.9x | 3.1x | 5.6x | 7.6x | 3.2x | 10.6x | 9.3x | 10.7x |
| Price / earnings | — | 22.8x | 14.0x | 12.8x | 18.6x | 40.0x | 33.8x | 13.0x | 42.4x | 33.6x | 104.8x |
| Price / free cash flow | — | — | — | 16.5x | 17.5x | 37.3x | 35.9x | 21.0x | 46.8x | 35.6x | 41.7x |
| EV / EBITDA | — | 22.1x | — | 8.4x | 15.4x | 30.8x | 27.0x | 12.7x | 47.9x | 34.2x | 40.4x |
Weak moat
How hard Camtek's competitive advantage looks for rivals to wear away, judged from 5 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.
Gross margin has been a median 48.7%, moving by 7.1 percentage points (standard deviation) across 5 years.
Operating margin has been a median 1.3%; its worst year was -19.6%.
Free cash flow was positive in 4 of 5 years, at a median 5.9% of revenue.
AI disruption exposure: Low. In this industry, the business rests on physical assets, regulated networks or products AI itself depends on.
Next results: November 4, 2026, before the open. Analysts expect revenue of $161m and EPS of $0.99 (range $0.96 to $1.02) for the quarter.
| Fiscal year | EPS | Growth | Revenue | Growth |
|---|---|---|---|---|
| Current | $3.63 | +11% | $595m | +20% |
| Next | $5.08 | +40% | $801m | +35% |
Next year's EPS estimate has moved +13.4% in 90 days, across 10 analysts.
The consensus EPS forecast for the current fiscal year is +3.7% on 90 days ago. In the last 30 days, 10 analysts raised Camtek LTD's forecast and 0 cut it.
Average of analysts' published estimates (third-party data).
| Period | Current fiscal year | Next fiscal year |
|---|---|---|
| 90 days ago | $3.50 | $4.48 |
| 60 days ago | $3.62 | $4.82 |
| 30 days ago | $3.62 | $4.79 |
| 7 days ago | $3.62 | $4.79 |
| Now | $3.63 | $5.08 |
| Quarter to | Estimate | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | $0.76 | $0.78 | +2.8% |
| Mar 2026 | $0.68 | $0.70 | +2.2% |
| Dec 2025 | $0.81 | $0.81 | −0.4% |
| Sept 2025 | $0.80 | $0.82 | +2.1% |
Adjusted EPS as companies report it, against the average analyst estimate.
| Calendar year | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 to date |
|---|---|---|---|---|---|---|
| Return | ||||||
| CAMT | +110% | −52% | +216% | +18% | +32% | +2% |
| Industry peers (median) | +65% | −36% | +29% | −4% | +38% | +28% |
| S&P 500 | +29% | −18% | +26% | +25% | +18% | +11% |
| Months that ended higher | ||||||
| CAMT | 67% | 17% | 83% | 50% | 67% | 46% |
| S&P 500 | 75% | 42% | 67% | 75% | 75% | 46% |
| Largest fall from a high during the year | ||||||
| CAMT | −24% | −56% | −22% | −48% | −53% | −48% |
| S&P 500 | −5% | −25% | −10% | −8% | −19% | −9% |
Worst fall since November 2, 2015: 63% from July 8, 2024 to April 4, 2025. Getting back needed a 171% gain, reached on January 12, 2026, 283 days after the low.
How Camtek LTD’s listed options are priced, and three ways to use them that follow from our valuation. Quotes are delayed, read November 2, 2026. Check the live chain at your broker before trading.
Not offered: rated Sell.
We suggest selling a put only on well-rated companies, at a strike where the price you would pay if assigned (strike less premium) is at or below our fair value.
Not offered: no liquid call at or above our price target — the model says the upside is worth more than any listed strike.
For holders: sell a call at a strike at or above our fair value, so the shares are only sold at a price the model calls full value.
Not offered: no liquid put and call pair for the same expiry.
For holders of a stock trading at or above our fair value: buy a put for a floor and sell a call to pay for it.
General research, not personal advice. Options can lose you more than you expect and are not suitable for everyone: put sellers can be made to buy shares that keep falling, call sellers give up gains above the strike, and results or news can move prices sharply. Chances shown are approximations from each option’s delta. Spreads, fees and early assignment are not modelled.
Source: SEC EDGAR filings. Retrieved Invalid Date.
| Period | Revenue (TTM) |
|---|---|
| FY14 Q4 | $88.3M |
| FY15 Q4 | $69.4M |
| FY16 Q4 | $79.2M |
| FY17 Q4 | $93.5M |
| FY18 Q4 | $123.2M |
| FY19 Q4 | $134M |
| FY20 Q4 | $155.9M |
| FY21 Q4 | $269.7M |
| FY22 Q4 | $320.9M |
| FY23 Q4 | $315.4M |
| FY24 Q4 | $429.2M |
| FY25 Q4 | $496.1M |
Source: SEC EDGAR filings. Retrieved Invalid Date.
| Period | Revenue growth, TTM YoY |
|---|---|
| FY14 Q4 | 3.4% |
| FY15 Q4 | -21.4% |
| FY16 Q4 | 14.2% |
| FY17 Q4 | 18.0% |
| FY18 Q4 | 31.8% |
| FY19 Q4 | 8.8% |
| FY20 Q4 | 16.3% |
| FY21 Q4 | 73.0% |
| FY22 Q4 | 19.0% |
| FY23 Q4 | -1.7% |
| FY24 Q4 | 36.1% |
| FY25 Q4 | 15.6% |
Source: SEC EDGAR filings. Retrieved Invalid Date.
| Period | Operating margin (TTM) |
|---|---|
| FY14 Q4 | 5.8% |
| FY15 Q4 | -19.6% |
| FY16 Q4 | 2.5% |
| FY17 Q4 | -3.2% |
| FY18 Q4 | 16.3% |
| FY19 Q4 | 16.4% |
| FY20 Q4 | 14.5% |
| FY21 Q4 | 26.3% |
| FY22 Q4 | 25.4% |
| FY23 Q4 | 20.7% |
| FY24 Q4 | 25.2% |
| FY25 Q4 | 25.8% |
Source: SEC EDGAR filings. Retrieved Invalid Date.
| Period | FCF margin (TTM) |
|---|---|
| FY14 Q4 | 5.9% |
| FY15 Q4 | -0.8% |
| FY16 Q4 | -23.8% |
| FY17 Q4 | -1.7% |
| FY18 Q4 | 11.7% |
| FY19 Q4 | 17.4% |
| FY20 Q4 | 14.8% |
| FY21 Q4 | 21.1% |
| FY22 Q4 | 15.4% |
| FY23 Q4 | 22.5% |
| FY24 Q4 | 26.1% |
| FY25 Q4 | 25.6% |
Each dollar Camtek took in during FY2025, followed through to profit: what it cost to make, what went on research and running the business, and what was left after tax.
| Revenue | $496M | |
|---|---|---|
| Cost of revenue | $246M | 49.5% of revenue |
| Gross profit | $250M | 50.5% of revenue |
| Research and development | $48.3M | 9.7% of revenue |
| Selling, general and admin | $73.8M | 14.9% of revenue |
| Operating income | $128M | 25.8% of revenue |
| Interest and other | $75.9M | 15.3% of revenue |
| Net income | $50.7M | 10.2% of revenue |
| Fiscal year | 2009 Dec 2009 | 2010 Dec 2010 | 2011 Dec 2011 | 2012 Dec 2012 | 2013 Dec 2013 | 2014 Dec 2014 | 2015 Dec 2015 | 2016 Dec 2016 | 2017 Dec 2017 | 2018 Dec 2018 | 2019 Dec 2019 | 2020 Dec 2020 | 2021 Dec 2021 | 2022 Dec 2022 | 2023 Dec 2023 | 2024 Dec 2024 | 2025 Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income | |||||||||||||||||
| Revenue | 54 | 88 | 107 | 85 | 85 | 88 | 69 | 79 | 93 | 123 | 134 | 156 | 270 | 321 | 315 | 429 | 496 |
| Gross profit | 17 | 38 | 47 | 37 | 34 | 41 | 32 | 32 | 46 | 61 | 65 | 73 | 137 | 160 | 148 | 210 | 250 |
| EBITDA | −8 | 7 | 11 | 2 | 4 | 7 | −12 | 4 | −1 | 22 | 24 | 25 | 74 | 86 | 71 | 119 | 140 |
| Operating income | −11 | 5 | 9 | −0 | 1 | 5 | −14 | 2 | −3 | 20 | 22 | 23 | 71 | 81 | 65 | 108 | 128 |
| Net income | −12 | 3 | 5 | 0 | 0 | 3 | −10 | 5 | 14 | 19 | 22 | 22 | 60 | 80 | 79 | 119 | 51 |
| Diluted EPS | −$0.40 | $0.09 | $0.18 | $0.00 | $0.00 | $0.11 | −$0.30 | $0.13 | $0.39 | $0.51 | $0.57 | $0.54 | $1.34 | $1.68 | $1.63 | $2.42 | $1.04 |
| Growth (year on year) | |||||||||||||||||
| Revenue | — | +64.0% | +21.9% | −21.0% | +1.0% | +3.4% | −21.4% | +14.2% | +18.0% | +31.8% | +8.8% | +16.3% | +73.0% | +19.0% | −1.7% | +36.1% | +15.6% |
| EBITDA | — | — | +60.1% | −81.5% | +76.9% | +96.3% | −260.0% | — | −123.0% | — | +9.6% | +3.1% | +196.5% | +16.1% | −16.8% | +66.8% | +17.9% |
| Operating income | — | — | +86.0% | −100.2% | — | — | −364.3% | — | −250.4% | — | +9.7% | +3.0% | +213.4% | +15.0% | −19.7% | +65.2% | +18.6% |
| Net income | — | — | +91.0% | −99.9% | — | — | −403.1% | — | +194.9% | +34.2% | +17.4% | −0.9% | +176.8% | +32.6% | −1.6% | +50.7% | −57.2% |
| Diluted EPS | — | — | +100.0% | −100.0% | — | — | −372.7% | — | +200.0% | +30.8% | +11.8% | −5.3% | +148.1% | +25.4% | −3.0% | +48.5% | −57.0% |
| Margins | |||||||||||||||||
| Gross margin | 32.7% | 43.8% | 44.3% | 43.8% | 40.3% | 46.4% | 45.9% | 41.0% | 48.7% | 49.4% | 48.3% | 47.0% | 50.9% | 49.8% | 46.8% | 48.9% | 50.5% |
| EBITDA margin | −15.6% | 8.1% | 10.6% | 2.5% | 4.4% | 8.3% | −16.9% | 5.0% | −1.0% | 17.9% | 18.0% | 15.9% | 27.3% | 26.7% | 22.6% | 27.7% | 28.2% |
| Operating margin | −19.6% | 5.5% | 8.4% | −0.0% | 1.3% | 5.8% | −19.6% | 2.5% | −3.2% | 16.3% | 16.4% | 14.5% | 26.3% | 25.4% | 20.7% | 25.2% | 25.8% |
| Net margin | −22.1% | 3.2% | 5.0% | 0.0% | 0.0% | 3.8% | −14.6% | 6.0% | 14.9% | 15.2% | 16.4% | 14.0% | 22.4% | 24.9% | 24.9% | 27.6% | 10.2% |
| Free-cash-flow margin | 6.1% | −2.0% | 8.2% | 2.3% | 3.3% | 6.1% | −0.7% | −23.5% | −1.6% | 11.8% | 17.4% | 15.0% | 21.1% | 15.5% | 22.6% | 26.1% | 25.7% |
| Cash flow | |||||||||||||||||
| Cash from operations | 4 | −0 | 10 | 4 | 5 | 6 | 2 | −17 | 2 | 17 | 25 | 26 | 61 | 58 | 79 | 122 | 142 |
| Capital spending | 0 | 2 | 1 | 2 | 2 | 1 | 2 | 1 | 3 | 2 | 1 | 2 | 4 | 8 | 8 | 10 | 14 |
| Free cash flow | 3 | −2 | 9 | 2 | 3 | 5 | −0 | −19 | −2 | 15 | 23 | 23 | 57 | 50 | 71 | 112 | 127 |
| Stock-based pay | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 3 | 4 | 6 | 11 | 13 | 15 | 17 |
| Free cash flow after stock pay | 3 | −2 | 8 | 2 | 2 | 5 | −1 | −19 | −2 | 13 | 20 | 19 | 51 | 39 | 59 | 98 | 111 |
| Balance sheet | |||||||||||||||||
| Cash | 16 | 10 | 22 | 19 | 16 | 18 | 31 | 20 | 44 | 55 | 38 | 106 | 242 | 148 | 120 | 126 | 178 |
| Total debt | 0 | 0 | 9 | 10 | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 195 | 196 | 197 | 198 | 520 |
| Net debt (negative = net cash) | −16 | −10 | −13 | −9 | −16 | −18 | −31 | −20 | −44 | −55 | −38 | −106 | −47 | 48 | 77 | 72 | 342 |
| Diluted shares | 29m | 30m | 30m | 30m | 30m | 31m | 33m | 35m | 36m | 37m | 38m | 40m | 45m | 48m | 49m | 49m | 50m |
| Returned to shareholders | |||||||||||||||||
| Dividends | — | — | — | — | — | — | — | — | 5 | 5 | 7 | 0 | 0 | 0 | 0 | 60 | 0 |
| Total returned | — | — | — | — | — | — | — | — | 5 | 5 | 7 | 0 | 0 | 0 | 0 | 60 | 0 |
| Last 12 months unless stated | CAMT | COHU | VECO | ACLS | NVMI | KLIC | Median |
|---|---|---|---|---|---|---|---|
| Revenue, last 12 months | $496m | $569m | $683m | $866m | $881m | $950m | $994m |
| Revenue growth, last 12 months | 15.6% | 34.0% | −2.5% | −3.3% | 31.0% | 44.4% | 15.8% |
| Revenue growth, 3-year average | 79.8% | −6.2% | 2.1% | −5.4% | 99.1% | 4.8% | 7.8% |
| Revenue growth, latest quarter | — | 37.0% | 16.5% | 10.6% | — | 122.6% | 33.7% |
| Gross margin | 50.5% | 42.7% | 37.9% | 43.0% | 57.4% | 48.2% | 47.7% |
| Operating margin | 25.8% | −2.4% | 2.7% | 10.3% | 28.8% | 13.2% | 13.2% |
| Operating margin, 3-year average | 16.3% | −10.5% | 7.6% | 17.2% | 27.3% | 0.9% | 16.0% |
| Net margin | 10.2% | −4.0% | 3.4% | 10.7% | 29.4% | 12.2% | 10.9% |
| Cash from operations / revenue | 28.6% | 11.6% | 14.6% | 8.7% | 27.9% | 5.8% | 18.6% |
| Free-cash-flow margin | 25.6% | 9.8% | 12.5% | 7.6% | 24.7% | 4.3% | 15.0% |
| Free-cash-flow margin, 3-year average | 15.0% | 0.6% | 8.1% | 11.7% | 26.8% | 10.0% | 11.9% |
| Stock pay / revenue | 3.4% | 4.0% | 5.3% | 2.5% | 3.0% | 2.9% | 2.4% |
| Change in share count | 1.2% | 4.7% | 2.3% | −3.7% | 2.1% | −1.0% | 0.8% |
| Measure | Company | Peer median | Rank |
|---|---|---|---|
| Revenue growth Growth | 15.6% | 15.8% | 12 of 20 |
| Change in growth rate Growth | -20.5pp | +7.5pp | 20 of 20 |
| Gross margin Profitability | 50.5% | 48.2% | 7 of 19 |
| Operating margin Profitability | 25.8% | 13.2% | 6 of 19 |
| Net margin Profitability | 10.2% | 11.1% | 12 of 20 |
| Free-cash-flow margin Cash generation | 25.6% | 17.5% | 4 of 20 |
| Stock pay as % of revenue Cash generation | 3.4% | 2.5% | 17 of 20 |
| Change in share count Balance sheet | 1.2% | 0.9% | 11 of 19 |
Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).
| Manager | Value | Shares | Share of 13F value | Shares QoQ |
|---|---|---|---|---|
| Migdal Insurance & Financial Holdings Ltd. | $432M | 2.6M | 13.4% | ▲ 37.3% |
| Harel Insurance Investments & Financial Services Ltd. | $363M | 2.2M | 11.3% | ▼ 3.3% |
| Wasatch Advisors LP | $346M | 2.1M | 10.8% | ▼ 22.2% |
| Menora Mivtachim Holdings Ltd. | $342M | 2.1M | 10.6% | ▲ 1.3% |
| Clal Insurance Enterprises Holdings Ltd | $302M | 1.9M | 9.4% | ▲ 0.3% |
| Jane Street Group, LLC | $146M | 895K | 4.5% | ▲ 287.6% |
| Vanguard Capital Management LLC | $129M | 811K | 4.0% | ▲ 4.4% |
| Y.D. More Investments Ltd | $126M | 797K | 3.9% | ▲ 1.7% |
| Federated Hermes, Inc. | $74.9M | 459K | 2.3% | ▼ 6.4% |
| Goldman Sachs Group Inc | $50.2M | 308K | 1.6% | ▼ 21.8% |
| Oberweis Asset Management Inc/ | $41.3M | 253K | 1.3% | ▲ 13.7% |
| Vanguard Fiduciary Trust Co | $41M | 257K | 1.3% | ▲ 3.5% |
From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Camtek LTD's complete shareholder register. Values are as reported by the filers ; 2 inconsistently scaled filing rows were excluded.
| Insider | Date | Trade | Shares | Price | Value |
|---|---|---|---|---|---|
| Geva-Dvash Orit Vice President, HR | August 17, 2026 | Sell | 508 | $175.00 | $88,900 |
| Andorn Karni Yarl Director | August 14, 2026 | Sell | 3,176 | $164.40 | $522,134 |
| Amit Rafi Chief Executive Officer | August 13, 2026 | Sell | 6,250 | $170.52 | $1.1M |
| Langer Ram Chief Operating Officer | August 13, 2026 | Sell | 6,387 | $172.32 | $1.1M |
| Andorn Karni Yarl Director | August 13, 2026 | Sell | 880 | $172.74 | $152,011 |
| Andorn Karni Yarl Director | August 13, 2026 | Sell | 1,476 | $172.12 | $254,049 |
| Eisenberg Moshe Chief Financial Officer | August 12, 2026 | Sell | 645 | $172.67 | $111,372 |
| Aviram Lior Director | August 12, 2026 | Sell | 1,666 | $172.73 | $287,768 |
| Aviram Lior Director | August 12, 2026 | Sell | 1,681 | $175.00 | $294,175 |
| Geva-Dvash Orit Vice President, HR | August 12, 2026 | Sell | 415 | $174.06 | $72,235 |
| Eisenberg Moshe Chief Financial Officer | August 11, 2026 | Sell | 3,759 | $160.06 | $601,666 |
| Aviram Lior Director | August 11, 2026 | Sell | 1,658 | $164.00 | $271,912 |
From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.
| Data | Last updated | Source |
|---|---|---|
| Share price | Exchange closing prices | |
| News and updates | Company releases and SEC 8-K filings | |
| Analyst estimates | Aggregated analyst estimates | |
| Valuation and scores | Our models, from the filed figures |
New research on the companies we cover arrives in the weekly email. Free, one email a week.
